Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies

Systemic lupus erythematosus (SLE) and bullous pemphigoid (BP) are chronic autoimmune diseases in which B cells play an important pathogenic role in the different stages of the disease. B cell-targeted therapies have been suggested as a new rational approach for treating SLE. Rituximab (RTX), an ant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Med (Lausanne)
Main Authors: Petricca, Luca, Gigante, Maria Rita, Paglionico, Annamaria, Costanzi, Stefano, Vischini, Gisella, Di Mario, Clara, Varriano, Valentina, Tanti, Giacomo, Tolusso, Barbara, Alivernini, Stefano, Grandaliano, Giuseppe, Ferraccioli, Gianfranco, Gremese, Elisa
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657367/
https://ncbi.nlm.nih.gov/pubmed/33195302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.553075
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados